NCT02263508 · Interventional trial
Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma
Overall registry status Terminated
Phase 3
Conditions Melanoma
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory